With recent data providing “solid evidence” for nicotinamide riboside’s effects on inflammation and body composition, combining NR with exercise will see us “really get some place”, says Dr Charles Brenner.
While sales of immunity health products have been strong for most of 2020, consumer interest in other categories is also surging, from sleep and stress management to a resurgence in sports nutrition, says the COO of The Vitamin Shoppe.
The US Food and Drug Administration may be willing to sit down with a company about a possible NDI submission for full-spectrum hemp extracts, says Steve Mister, president and CEO of the Council for Responsible Nutrition (CRN).
AmericanMarijuana.org recently surveyed over 1,000 consumers who give their pets Cannabidiol (CBD). The survey aimed to gauge the attitudes of pet owners, their veterinarians, and what factors influenced their decisions.
Many recent warning letters from the Federal Trade Commission about COVID-19 are warranted, says UNPA’s Loren Israelsen, but some targeting health practitioners and what our industry has to offer in the broader immunity discussion may hint at redefining...
FDA has stated it is making ‘substantial progress’ with CBD, and a new enforcement guidance could be very significant for the industry, said NPA’s Dr Daniel Fabricant, but he said the Agency needs to ‘get in the game’ for NDIs.